REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/06/2025
Back to search
Official data from USPTO
DS INPHARMATICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
10/07/2025
Trademark type
Combined
Nice classes
35, 42, 45
Filing date
08/05/2019
Registration date
10/06/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/06/2020
Last transaction
10/07/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/01/2019
First use in commerce
01/01/2019
Drawing code
3
Owner type
16
Owner location
Green Lane, PA
Examiner
MCMORROW,RONALD G
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of three stacked rectangles with one rectangle having a rounded corner and to the right of the rectangles are the letters "DS" and on the bottom of the mark is the word "INPHARMATICS".
Holders and representatives
Holders
Design Space InPharmatics LLC
Representatives
Alexander T. Bara IPHORGAN LTD.
Technical classification
Nice Classes
Class 35Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Regulatory submission managementassisting others in preparing and filing applications for new drugs with governmental regulatory bodies; consulting services in the field of commercial administration of the licensing of pharmaceutical products of others
Class 42
Providing scientific research services in the fields of pharmaceutical design and developmentpharmaceutical chemistrypharmaceutical manufacturing and controls; technological due diligence consulting in the field of pharmaceutical technology
Class 45
Regulatory compliance consulting in the fields of pharmaceutical developmentpharmaceutical chemistrypharmaceutical manufacturing and controls; consulting services in the field of pharmaceutical licensing requirements
Publications
History of USPTO decisions and trademark events.
27 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/06/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/04/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/03/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/27/2020
IROA
RESPONSE TO ITU OFFICE ACTION ENTERED
08/25/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/25/2020
IUFF
USE AFFIDAVIT FAILED FORMALITIES
08/13/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/12/2020
IUAF
USE AMENDMENT FILED
07/30/2020
EISU
TEAS STATEMENT OF USE RECEIVED
07/30/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/23/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/28/2020
PUBO
PUBLISHED FOR OPPOSITION
04/28/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/08/2020
ALIE
ASSIGNED TO LIE
03/23/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/15/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/14/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/13/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/13/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/09/2019
GNRT
NON-FINAL ACTION E-MAILED
10/09/2019
CNRT
NON-FINAL ACTION WRITTEN
10/09/2019
DOCK
ASSIGNED TO EXAMINER
10/05/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/23/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/22/2019
NWAP
NEW APPLICATION ENTERED
08/08/2019
Continuous trademark protection
Get notified about every new filing that threatens DS INPHARMATICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.